期刊文献+

环氧合酶-2、血管内皮生长因子及上皮钙黏素在甲状腺癌中的表达及其临床意义 被引量:4

Expression and their clinical significance of COX-2, VEGF and E-cadherin in thyroid carcinoma
原文传递
导出
摘要 目的 探讨环氧合酶-2(COX-2)、血管内皮生长因子(VEGF)、上皮钙黏素(E-cadherin)在甲状腺癌中的表达及其临床病理意义.方法 采用免疫织织化学SP法检测68例甲状腺癌、16例甲状腺瘤及16例正常甲状腺组织中COX-2、E-cadherin、VEGF的表达,并对甲状腺癌组织学分型、临床病理分期及淋巴结转移进行对比分析.结果 68例甲状腺癌中COX-2、VEGF、E-cadherin的阳性表达率分别为63.2%、66.2%和60.3%,和甲状腺瘤相比较差异有统计学意义(P〈0.05).甲状腺癌中COX-2、VEGF、E-cadherin的表达在不同临床病理分期、淋巴结转移状态差异均有统计学意义(P〈0.05).E-cadherin与VEGF、COX-2的表达均呈负相关(r=-0.423,P〈0.01 r=-0.413,P〈0.01) COX-2与VEGF的表达呈正相关(r=0.659,P〈0.01).结论 COX-2、E-cadherin、VEGF在甲状腺癌的发生、发展中起着重要作用,三者联合检测可为甲状腺癌恶性程度和预后的判断提供有效证据. Objective To study the expression of COX-2,E-cadherin and VEGF in thyroid carcinoma and its clinicopathological significance.Methods Expression of COX-2,E-cadherin and VEGF was detected in 68 cases with thyroid carcinoma,16 cases with thyroid adenomas and 16 cases of normal thyroid tissue by SP immunohistochemical method.Results The expression of COX-2,E-cadherin and VEGF in 68 cases with thyroid carcinoma was 63.2%,61.8%and 66.2%,respectively,with significant difference(P〈0.05)compared with the expression of these proteins in thyroid adenomas.Expression of COX-2,VEGF and E-cadherin Was significantly different with TNM stages and with lymph node metastasis status(P〈0.05).Expression of E-cadherin was negatively correlated to the expression of VEGF and COX-2(r=-0.423,P〈0.01 r=-0.413.P〈0.01).Expression of COX-2 was positively related to the expression of VEGF(r=0.659,P〈0.01). Conclusion COX-2, E-cadherin and VEGF play important roles in carcinogenesis and development of thyroid carcinoma. Combined detection can provide valuable evidence for estimation of aggressive degree and prognosis of thyroid carcinoma.
出处 《肿瘤研究与临床》 CAS 2010年第6期400-403,共4页 Cancer Research and Clinic
关键词 甲状腺肿瘤 环氧合酶-2 上皮钙黏素 血管内皮生长因子 免疫组织化学 Thyroid neoplasms Cyclookygenase-2 E-cadherin Vascular endothelial growth factors Immunohistochemistry
  • 相关文献

参考文献15

  • 1Rezk S,Khan A.Role of immunohistochemistry in the diagnosis and progression of follicular Epithelium-derived thyroid carcinoma.Appl Immunohistochem Mol Morphol,2005,13:256-264.
  • 2Hermanova M,Tma J,Nenutil R,et al.Expression of COX-2 is associated with accumulation of p53 in pancreatic cancer:analysis of COX-2 and p53 expression in premalignant and malignant ductal pancreatic lesions.Eur J Gastroenterol Hepatol,2008,20:732-739.
  • 3Chan LW,Moses MA,Goley E,et al.Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy:a longitudinal.study of pmtein kinetics throughout tumor progression and therapy.J Clin Oncol,2004,22:499-506.
  • 4Ben CC,Miao XH,Yang B,et al.Methylation status of the fragile histidine triad and E-cadherin genes in plasma of cervical cancer patients.Int J Gynecol Cancer,2006,16:1862-1867.
  • 5Lee JS,Choi YD,Lee JH,et al.Expression of cyclooxygenase-2 in epithelial ovarian tumors and its relation to vascular endothelial growth factor and p53 expression.Int J Gynecol Cancer,2006,16:247-253.
  • 6Joo YE,Rew JS,Seo YH,et al.Cyclooxygenase-2 overexpression correlates with vascular endothelial growth factor expression and tumor angiogenesis in gastric cancer.J Clin Gastroenterol,2003,37:28-33.
  • 7Specht MC,Tucker ON,Hecever M,et al.Cyclooxygenase-2expression in.thyroid nodules.J Clin Endecrinol Metab,2002,87:358-363.
  • 8Ito Y,Yoshida H,Nakano K,et al.Cyclooxygenase-2 expression in thyroid neoplasms.Histopathology,2003,42:492-497.
  • 9Milano A,Chiofalo MG,BasileM,et al.New molecular targeted therapies in thyroid cancer.Anticancer Drugs,2006,17:869-879.
  • 10Alp B,Yesim E,Yersu K,et al.Role of vascular endothelial growth factor in the prognosis of papillary thyroid cancer,Endocrinologist,2006,16:168-171.

同被引文献41

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部